retatrutide peptide obesity triple hormone receptor agonist First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the Retatrutide for Obesity | Patchmd
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28

























![Squee, the Immortal [Dominaria] Explorers of Ixalan](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/632c8da9-0204-5d0d-bea9-92e19755e143_f1df8eb5-e969-4122-836e-89e8d5ce6550.jpg?v=1697581562)


![Treasured Find [Return to Ravnica] BW14](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/84aea61f-130b-57a3-b309-ac1fd4af45ab_38c731d4-0f5b-48b1-a9fc-4ad7625391c3.jpg?v=1697581588)
![Fork [Revised Edition] SWSH090](https://cdn.shopify.com/s/files/1/0824/7345/1830/products/367cc544-34f7-5033-8e11-f6eba3437a50_a4c72427-aa87-4005-a246-d6516c083f89.jpg?v=1697581572)